Ascendis Pharma (ASND) PT Raised to $312 at Oppenheimer
Oppenheimer analyst Leland Gershell raised the price target on Ascendis Pharma (NASDAQ: ASND) to $312.00 (from $304.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)